Plenty of studies have proved that CDC20 functioned as the carcinogenic factor and was highly expressed in a variety of solid tumors and hematological malignancies, including breast cancer [16], lung cancer [17], gastric cancer [18], hepatocellular carcinoma [19], colorectal cancer [20], pancreatic cancer [21], bladder cancer [22], oral squamous cell carcinoma [23], ovarian cancer [24], glioblastoma [25], multiple myeloma [26] and diffuse large B-cell lymphoma [27]. Here, CDC20 is linked to diffuse large B-cell lymphoma.